Greg Daniel, PhD
Gregory Daniel, PhD, MPH, serves as Vice President, Head of Policy Innovation, Evidence & Engagement at Eli Lilly and Company. In this role, Greg leads efforts in policy innovation and thought leadership, policy evidence development, and external engagement to promote innovation and improve access and affordability in healthcare. Additionally, Greg has led Eli Lilly’s Global Public Policy […]
Jennifer Graff, PharmD
Dr. Graff is the founder of Innov8 Health Policy, where she helps biopharmaceutical companies and patient advocacy groups turn the confusion and complexity into actions so they can navigate, translate, and modernize drug payment policies, enabling faster patient access, clearer coverage pathways, and improving incentives for innovation. With leadership roles spanning managed care pharmacy (Academy […]
Kirsten Axelsen
Kirsten is a biopharmaceutical advisor who works with leaders in healthcare helping to develop business practices that lead to affordable access to medicines, positive public perception, and sustained investment in scientific advancement. her guidance is grounded in analytics and empirical evidence and a keen understanding of how the actors in the life sciences respond to […]
Yasmeen Long, MA
Yasmeen Long, M.A., is a nationally recognized expert in biomedical research, health outcomes, domestic and global health policy, patient advocacy, and stakeholder engagement. Long has earned media featured in Forbes, Modern Healthcare, Bloomberg Law, Endpoints News, National Journal, Science News, The Scientist Magazine, and Regulatory Focus. Long is also recognized as a consultant and strategic advisor for […]
Josh Trent
Josh Trent is the CEO of Leavitt Partners, based in Leavitt Partners’ Washington, D.C. office. Josh has more than a decade and a half of experience in the federal government—from the White House, to the U.S. Department of Health and Human Services, to the U.S. Senate and U.S. House on Capitol Hill. In his role at […]
Eleanor Perfetto, PhD, MS
Dr. Perfetto is a recognized caregiver and patient advocate. She is a current member of the Brain Injury Association of America’s Board of Directors and past secretary and governance-committee chair, as well as past board chair for the Concession Legacy Foundation. She has worked in government, industry, consulting, academic, and non-profit organizations. Today, she consults […]
Dan Leonard
Dan Leonard serves as Executive Director of We Work For Health (WWFH). With over 20 years of management associations – including the National Pharmaceutical Council and the Association for Accessible Medicines – at the highest levels, Leonard has had a unique 360-degree view of the healthcare ecosystem in America from the payor, innovative and generic […]
Sean Dickson, JD, MPH
Sean Dickson leads pharmaceutical policy at AHIP, the trade association for health plans. Throughout his career, Sean has represented numerous stakeholders in pharmaceutical policy, including branded manufacturers, state public health programs, and health plans. Prior to AHIP, Sean led pharmaceutical policy research at the Pew Charitable Trusts and the West Health Policy Center. Sean’s academic […]
Margaret Kyle, PhD
Margaret Kyle (Mines Paris and CEPR) currently holds the Chair in Intellectual Property and Markets for Technology at Mines Paris – PSL. Her research concerns innovation, productivity and competition. Her papers have been published in a number of journals, including the Quarterly Journal of Economics, Review of Economics and Statistics, Journal of Economic Perspectives, RAND […]
Tiffany Westrich-Robertson
Tiffany Westrich-Robertson is the CEO and original founder of AiArthritis (the International Foundation for Autoimmune & Autoinflammatory Arthritis) and a person living with axial spondyloarthritis. She also leads the Ensuring Access through Collaborative Health (EACH) and associated Patient Inclusion Council (PIC), a national, two-part, disease agnostic coalition advocating for drug affordability policies that benefit patients. […]